Cancer Institute And Hospital, Chinese Academy Of Medical Sciences
Clinical trials sponsored by Cancer Institute And Hospital, Chinese Academy Of Medical Sciences, explained in plain language.
-
Experimental cell injection targets Hard-to-Treat brain lining tumors
Disease control CompletedThis early study tested a new treatment called QH104 for people with solid tumors that have spread to the lining of the brain (meningeal metastases). The treatment uses specially engineered immune cells (B7H3 CAR-γδ T cells) injected directly into the fluid around the brain. Only…
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 04:16 UTC
-
New combo therapy aims to improve sarcoma surgery outcomes
Disease control CompletedThis study tested giving a targeted drug (apatinib) along with radiation therapy before surgery for soft tissue sarcoma in the arms, legs, or trunk. The goal was to see if this combination is safe and helps control the disease. 30 adults took part in this phase 2 trial.
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New combo attack on rectal cancer shows promise in reducing recurrence
Disease control CompletedThis study looked at 180 adults with rectal cancer that had spread to nearby lymph nodes. It compared a strong three-drug chemo regimen (FOLFOXIRI) plus surgery to remove affected lymph nodes against standard chemo and radiation before surgery. The goal was to see if the new appr…
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
Shorter radiation may be just as good for breast cancer patients
Disease control CompletedThis study looked at 720 women with early-stage breast cancer who had surgery to remove the tumor. They were split into two groups: one got standard daily radiation for several weeks, and the other got a shorter course of higher-dose radiation. The goal was to see if the shorter …
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New drug combo before sarcoma surgery shows promise in early trial
Disease control CompletedThis study tested whether adding the drug fluzoparil to radiation therapy before surgery is safe and effective for people with soft tissue sarcoma in the arms, legs, or trunk. Fifty-two adults took part. The main goal was to see how many had major wound problems within 4 months a…
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New combo therapy shows promise for tough liver cancer cases
Disease control CompletedThis study tested a new treatment for people with advanced liver cancer that has spread into the major blood vessels of the liver. The treatment combines a special type of radiation (moderate-dose hypofractionated radiotherapy) with an immunotherapy drug called tislelizumab. The …
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Shorter radiation may be safer for early breast cancer patients
Disease control CompletedThis study looked at 140 women with early-stage, low-risk breast cancer to compare two radiation approaches after breast-conserving surgery. One group received radiation to the whole breast, while the other received a shorter course targeting only the tumor area. The goal was to …
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New radiation approach shows promise for small brain metastases
Disease control CompletedThis study tested a precise type of radiation called fractionated stereotactic radiotherapy (FSRT) in 33 adults with 1 to 4 small brain metastases (each 2 cm or smaller). The goal was to control the tumors while reducing the risk of a side effect called radiation necrosis, where …
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
Could a contrast dye drink cure Post-Surgery belly fluid? early trial shows promise
Disease control CompletedThis study tested whether drinking iohexol, a liquid usually used for X-ray scans, can help stop chylous ascites — a buildup of milky fluid in the belly that sometimes happens after cancer surgery. 42 adults who had this complication after abdominal or pelvic cancer surgery took …
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Second chance at normal bowel function after cancer surgery?
Knowledge-focused CompletedThis study looked at 143 people in China who needed a second surgery after their first rectal cancer operation failed or the cancer came back. The goal was to find out what helps these repeat surgeries succeed in letting patients poop normally again, without a permanent bag. Rese…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC
-
Second chance surgery for rectal cancer: what predicts success?
Knowledge-focused CompletedThis study looked at 143 people in China who needed a second surgery after rectal cancer treatment because of a leak or the cancer coming back. Researchers wanted to find out what factors help the repeat surgery succeed and whether patients can eventually poop normally again. The…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
Breast cancer radiation may trigger thyroid issues in some patients
Knowledge-focused CompletedThis study looked at 729 breast cancer patients who had surgery followed by radiation. Researchers checked their thyroid function before and after radiation to see how many developed hypothyroidism (an underactive thyroid). They also studied which radiation doses and techniques r…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
Blood test may predict lung cancer recurrence
Knowledge-focused CompletedThis study looked at 500 people with non-small cell lung cancer who had surgery. Researchers used a blood test to find circulating tumor cells (CTCs) and checked if the number or type of these cells could predict whether the cancer would come back. The goal was to learn how well …
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC